MA55206A - Polyribonucléotides circulaires et compositions pharmaceutiques associées - Google Patents
Polyribonucléotides circulaires et compositions pharmaceutiques associéesInfo
- Publication number
- MA55206A MA55206A MA055206A MA55206A MA55206A MA 55206 A MA55206 A MA 55206A MA 055206 A MA055206 A MA 055206A MA 55206 A MA55206 A MA 55206A MA 55206 A MA55206 A MA 55206A
- Authority
- MA
- Morocco
- Prior art keywords
- pharmaceutical compositions
- related pharmaceutical
- circular polyribonucleotides
- polyribonucleotides
- circular
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0091—Purification or manufacturing processes for gene therapy compositions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/532—Closed or circular
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Crystallography & Structural Chemistry (AREA)
- Analytical Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962813666P | 2019-03-04 | 2019-03-04 | |
| US201962825683P | 2019-03-28 | 2019-03-28 | |
| US201962840174P | 2019-04-29 | 2019-04-29 | |
| US202062967545P | 2020-01-29 | 2020-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA55206A true MA55206A (fr) | 2022-01-12 |
Family
ID=70110338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA055206A MA55206A (fr) | 2019-03-04 | 2020-03-04 | Polyribonucléotides circulaires et compositions pharmaceutiques associées |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220143062A1 (fr) |
| EP (1) | EP3935162A1 (fr) |
| JP (2) | JP2022523794A (fr) |
| KR (1) | KR20210135265A (fr) |
| CN (3) | CN121081491A (fr) |
| AU (1) | AU2020233404A1 (fr) |
| CA (1) | CA3128626A1 (fr) |
| IL (1) | IL285906A (fr) |
| MA (1) | MA55206A (fr) |
| WO (1) | WO2020181013A1 (fr) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11814627B2 (en) | 2016-06-20 | 2023-11-14 | The Board Of The Leland Stanford Junior University | Circular RNAs and their use in immunomodulation |
| CA3084824A1 (fr) | 2017-12-15 | 2019-06-20 | Flagship Pioneering Innovations Vi, Llc | Compositions comprenant des polyribonucleotides circulaires et leurs utilisations |
| EP3946466A2 (fr) | 2019-03-25 | 2022-02-09 | Flagship Pioneering Innovations VI, LLC | Compositions comprenant des polyribonucléotides circulaires modifiés et utilisations associées |
| CN116887866A (zh) | 2020-12-03 | 2023-10-13 | 巴特尔纪念研究院 | 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法 |
| EP4291229A4 (fr) * | 2021-02-09 | 2025-03-26 | Virginia Commonwealth University | Thérapies et vaccins à base de mini-arn circulaire et leurs procédés d'utilisation |
| EP4314281A1 (fr) * | 2021-03-26 | 2024-02-07 | Flagship Pioneering Innovations VII, LLC | Production de polyribonucléotides circulaires dans un système eucaryote |
| TW202305130A (zh) * | 2021-03-26 | 2023-02-01 | 美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 | 原核系統中環狀多核糖核苷酸之產生 |
| US20240263206A1 (en) * | 2021-03-26 | 2024-08-08 | Flagship Pioneering Innovations Vii, Llc | Compositions and methods for producing circular polyribonucleotides |
| JP2024516108A (ja) | 2021-04-07 | 2024-04-12 | バテル・メモリアル・インスティテュート | 非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術 |
| CN117425735A (zh) * | 2021-05-18 | 2024-01-19 | 旗舰创业创新第六有限责任公司 | 富集环状多核糖核苷酸的方法 |
| EP4341423A1 (fr) * | 2021-05-18 | 2024-03-27 | Flagship Pioneering Innovations VI, LLC | Procédés d'enrichissement de polyribonucléotides circulaires |
| US20250002898A1 (en) | 2021-07-27 | 2025-01-02 | Flagship Pioneering Innovations Vi, Llc | Devices, systems and methods for processing |
| DK4271818T3 (da) | 2021-09-17 | 2024-11-04 | Flagship Pioneering Innovations Vi Llc | Sammensætninger og fremgangsmåder til fremstilling af cirkulære polyribonukleotider |
| US20250027108A1 (en) * | 2021-10-29 | 2025-01-23 | CureVac SE | Improved circular rna for expressing therapeutic proteins |
| KR102488280B1 (ko) * | 2021-11-25 | 2023-01-16 | 주식회사 뉴클릭스바이오 | 신규한 부목 dna 및 이의 용도 |
| CN114317684B (zh) * | 2021-12-15 | 2023-12-26 | 南京大学 | 一种基于tna分子的细胞内镁离子成像的方法 |
| MX2024007307A (es) | 2021-12-17 | 2024-08-06 | Flagship Pioneering Innovations Vi Llc | Métodos de enriquecimiento de arn circular en condiciones desnaturalizantes. |
| US20250108134A1 (en) * | 2022-01-28 | 2025-04-03 | Beijing Changping Laboratory | Circular rna vaccines and methods of use thereof |
| EP4612296A1 (fr) * | 2022-10-31 | 2025-09-10 | Flagship Pioneering Innovations VI, LLC | Compositions et procédés de purification de polyribonucléotides |
| TW202438673A (zh) | 2023-01-09 | 2024-10-01 | 美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 | 疫苗及相關方法 |
| KR20250153793A (ko) | 2023-01-27 | 2025-10-27 | 세일 바이오메디슨스, 인크. | 변형된 지질 조성물 및 이의 용도 |
| WO2024167885A1 (fr) | 2023-02-06 | 2024-08-15 | Flagship Pioneering Innovations Vii, Llc | Compositions immunomodulatrices et procédés associés |
| CN116286916B (zh) * | 2023-02-24 | 2025-08-22 | 北京大学人民医院 | 一种改良的i型内含子核酶序列用于构建环状rna的方法及应用 |
| TW202517783A (zh) * | 2023-06-28 | 2025-05-01 | 香港商瑞毅生物科技（香港）有限公司 | 工程化的rna多核苷酸及其製備方法 |
| WO2025072751A1 (fr) | 2023-09-29 | 2025-04-03 | Battelle Memorial Institute | Compositions de nanoparticules polymères pour l'expression in vivo de polypeptides |
| WO2025087301A1 (fr) * | 2023-10-24 | 2025-05-01 | Therorna Shanghai Co., Ltd. | Arn circulaire codant pour glp-1 et son utilisation |
| WO2025106915A1 (fr) | 2023-11-17 | 2025-05-22 | Sail Biomedicines, Inc. | Polyribonucléotides circulaires codant le peptide 1 de type glucagon (glp-1) et leurs utilisations |
| WO2025106930A1 (fr) | 2023-11-17 | 2025-05-22 | Sail Biomedicines, Inc. | Polyribonucléotides circulaires codant le peptide 2 de type glucagon (glp-2) et leurs utilisations |
| US12441996B2 (en) | 2023-12-08 | 2025-10-14 | Battelle Memorial Institute | Use of DNA origami nanostructures for molecular information based data storage systems |
| TW202545974A (zh) | 2024-01-26 | 2025-12-01 | 美商旗艦先鋒創新有限責任（Ｖｉｉ）公司 | 免疫受體抑制蛋白及相關方法 |
| WO2025179198A1 (fr) | 2024-02-23 | 2025-08-28 | Sail Biomedicines, Inc. | Polyribonucléotides circulaires et arn linéaires non modifiés à immunogénicité réduite |
| WO2025227064A1 (fr) * | 2024-04-26 | 2025-10-30 | Renasci Biotechnologies, Inc. | Méthodes d'édition génomique pour le traitement d'une maladie cardiovasculaire et compositions destinées à être utilisées dans la mise en œuvre de celles-ci |
| WO2025240369A2 (fr) * | 2024-05-13 | 2025-11-20 | Helix Nanotechnologies Inc | Procédés de distribution de polyribonucléotides nus |
| WO2025240680A1 (fr) | 2024-05-16 | 2025-11-20 | Flagship Pioneering Innovations Vii, Llc | Protéines inhibitrices d'immunorécepteurs et procédés associés |
| WO2025245111A1 (fr) | 2024-05-22 | 2025-11-27 | Flagship Pioneering Innovations Vii, Llc | Protéines de ciblage d'immunorécepteurs et procédés associés |
| CN118581085A (zh) * | 2024-05-24 | 2024-09-03 | 国家纳米科学中心 | 一种翻译调控元件、表达载体、药物组合物、疫苗组合物、构建方法、表达目的蛋白的方法及应用 |
| CN118688370B (zh) * | 2024-08-27 | 2024-12-13 | 天津辰欣药物研究有限公司 | 一种抗病毒新药中间体的质量控制方法 |
| WO2026096919A1 (fr) | 2024-11-01 | 2026-05-07 | Sail Biomedicines, Inc. | Nouveaux lipides à cœur dipeptidique, vecteurs lipidiques et méthodes d'utilisation de ceux-ci |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06500014A (ja) | 1990-07-25 | 1994-01-06 | シンジーン，インコーポレイテッド | 多数の核酸相補体を生成させる環状伸長法 |
| US5426180A (en) | 1991-03-27 | 1995-06-20 | Research Corporation Technologies, Inc. | Methods of making single-stranded circular oligonucleotides |
| JPH07502898A (ja) | 1992-01-13 | 1995-03-30 | デューク・ユニバーシティー | 酵素ｒｎａ分子 |
| US5773244A (en) | 1993-05-19 | 1998-06-30 | Regents Of The University Of California | Methods of making circular RNA |
| US5766903A (en) | 1995-08-23 | 1998-06-16 | University Technology Corporation | Circular RNA and uses thereof |
| US6429301B1 (en) | 1998-04-17 | 2002-08-06 | Whitehead Institute For Biomedical Research | Use of a ribozyme to join nucleic acids and peptides |
| US6693086B1 (en) | 1998-06-25 | 2004-02-17 | National Jewish Medical And Research Center | Systemic immune activation method using nucleic acid-lipid complexes |
| US6210931B1 (en) | 1998-11-30 | 2001-04-03 | The United States Of America As Represented By The Secretary Of Agriculture | Ribozyme-mediated synthesis of circular RNA |
| CA2462144C (fr) | 2001-09-28 | 2016-09-20 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Molecules de micro-arn |
| EP2530157B1 (fr) | 2003-07-31 | 2016-09-28 | Regulus Therapeutics Inc. | Composés oligomères et compositions à utiliser dans la modulation de miARNs |
| JP5296328B2 (ja) | 2007-05-09 | 2013-09-25 | 独立行政法人理化学研究所 | １本鎖環状ｒｎａおよびその製造方法 |
| WO2010084371A1 (fr) | 2009-01-26 | 2010-07-29 | Mitoprod | Nouvelles molécules d'arn interférent circulaire |
| WO2011097480A1 (fr) | 2010-02-05 | 2011-08-11 | University Of Louisville Research Foundation, Inc. | Compositions exosomales et procédés pour le traitement de maladies |
| WO2013070324A1 (fr) | 2011-11-07 | 2013-05-16 | University Of Louisville Research Foundation, Inc. | Compositions de microvésicules dérivées de plante comestible pour le diagnostic et le traitement d'une maladie |
| EP3071515A2 (fr) | 2013-11-18 | 2016-09-28 | Rubius Therapeutics, Inc. | Complexes membrane synthétique- récepteur |
| EP3583946A1 (fr) | 2014-04-01 | 2019-12-25 | Rubius Therapeutics, Inc. | Enucleated hematopoietic cells avec une antigene exogenous |
| CA2955238A1 (fr) * | 2014-07-16 | 2016-01-21 | Moderna Therapeutics, Inc. | Polynucleotides circulaires |
| WO2016183482A1 (fr) | 2015-05-13 | 2016-11-17 | Rubius Therapeutics, Inc. | Agents thérapeutiques d'un complexe membrane-récepteur |
| US11000547B2 (en) | 2015-06-05 | 2021-05-11 | Dana-Farber Cancer Institute, Inc. | Compositions related to rna in circularized form |
| US20180362974A1 (en) | 2015-07-02 | 2018-12-20 | University Of Louisville Research Foundation, Inc. | EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DELIVERY OF miRNA AND METHODS FOR TREATMENT OF CANCER |
| PT3402491T (pt) | 2016-01-11 | 2022-03-03 | Rubius Therapeutics Inc | Composições e métodos relacionados com sistemas celulares terapêuticos multimodais para indicações de cancro |
| JP2019520829A (ja) | 2016-07-07 | 2019-07-25 | ルビウス セラピューティクス， インコーポレイテッド | 外来性ｒｎａを発現する治療的細胞系に関連する組成物及び方法 |
| EP3548050A1 (fr) | 2016-12-02 | 2019-10-09 | Rubius Therapeutics, Inc. | Compositions et méthodes se rapportant à des systèmes cellulaires destinés à pénétrer dans des tumeurs solides |
| CA3052142A1 (fr) | 2017-02-17 | 2018-08-23 | Rubius Therapeutics, Inc. | Cellules erythroides fonctionnalisees |
| ES3052812T3 (en) | 2017-05-08 | 2026-01-14 | Flagship Pioneering Innovations V Inc | Compositions for facilitating membrane fusion and uses thereof |
| CA3084824A1 (fr) * | 2017-12-15 | 2019-06-20 | Flagship Pioneering Innovations Vi, Llc | Compositions comprenant des polyribonucleotides circulaires et leurs utilisations |
| AR116016A1 (es) | 2018-08-24 | 2021-03-25 | Flagship Pioneering Innovations Vi Llc | Métodos para fabricar paquetes mensajeros vegetales |
-
2020
- 2020-03-04 JP JP2021551958A patent/JP2022523794A/ja not_active Withdrawn
- 2020-03-04 KR KR1020217031072A patent/KR20210135265A/ko active Pending
- 2020-03-04 CN CN202511242261.9A patent/CN121081491A/zh active Pending
- 2020-03-04 CA CA3128626A patent/CA3128626A1/fr active Pending
- 2020-03-04 CN CN202080017994.1A patent/CN113544269A/zh active Pending
- 2020-03-04 CN CN202511242250.0A patent/CN121081490A/zh active Pending
- 2020-03-04 AU AU2020233404A patent/AU2020233404A1/en active Pending
- 2020-03-04 MA MA055206A patent/MA55206A/fr unknown
- 2020-03-04 US US17/433,639 patent/US20220143062A1/en active Pending
- 2020-03-04 WO PCT/US2020/021037 patent/WO2020181013A1/fr not_active Ceased
- 2020-03-04 EP EP20716264.5A patent/EP3935162A1/fr active Pending
-
2021
- 2021-08-26 IL IL285906A patent/IL285906A/en unknown
-
2025
- 2025-03-13 JP JP2025040243A patent/JP2025090772A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2020181013A1 (fr) | 2020-09-10 |
| JP2022523794A (ja) | 2022-04-26 |
| KR20210135265A (ko) | 2021-11-12 |
| CA3128626A1 (fr) | 2020-09-10 |
| US20220143062A1 (en) | 2022-05-12 |
| CN113544269A (zh) | 2021-10-22 |
| EP3935162A1 (fr) | 2022-01-12 |
| AU2020233404A1 (en) | 2021-09-16 |
| JP2025090772A (ja) | 2025-06-17 |
| CN121081491A (zh) | 2025-12-09 |
| CN121081490A (zh) | 2025-12-09 |
| IL285906A (en) | 2021-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3817722A4 (fr) | Compositions pharmaceutiques comprenant du méloxicam | |
| IL284835A (en) | Pharmaceutical combination comprising tno155 and ribociclib | |
| EP3891149A4 (fr) | Inhibiteurs de ret, compositions pharmaceutiques et utilisations associées | |
| EP3891148A4 (fr) | Inhibiteurs de ret, compositions pharmaceutiques et utilisations associées | |
| EP3565550A4 (fr) | Compositions pharmaceutiques contenant du méloxicam | |
| EP3621621A4 (fr) | Compositions pharmaceutiques contenant du méloxicam | |
| EP3436482A4 (fr) | Anticorps, compositions pharmaceutiques et procédés | |
| EP3500255A4 (fr) | Compositions pharmaceutiques ophtalmiques et utilisations associées | |
| EP3426348A4 (fr) | Dérivé de 3-désoxy et compositions pharmaceutiques associées | |
| EP3603620A4 (fr) | Composition de liposome et composition pharmaceutique | |
| EP3541385A4 (fr) | Formulations pharmaceutiques | |
| EP3573614C0 (fr) | Compositions pharmaceutiques pour thérapie combinée | |
| MA55015A (fr) | Formulations pharmaceutiques | |
| EP3914234A4 (fr) | Compositions pharmaceutiques | |
| EP3897593A4 (fr) | Formulations de cannabinoïdes et compositions pharmaceutiques | |
| EP3946316A4 (fr) | Compositions pharmaceutiques de cannabidiol | |
| EP3773654A4 (fr) | Compositions médicamenteuses polypharmaceutiques et méthodes associées | |
| MA47516A (fr) | Composition pharmaceutique | |
| MA49837A (fr) | Compositions pharmaceutiques | |
| EP3582759A4 (fr) | Composition pharmaceutique bioéquivalente de bromhydrate de vortioxétine | |
| DK3908321T3 (da) | Farmaceutisk sammensætning | |
| CY1123408T1 (el) | Φαρμακευτικες συνθεσεις και χρηση των αυτων | |
| EP3646867A4 (fr) | Composition pharmaceutique | |
| EP3646863A4 (fr) | Composition pharmaceutique | |
| EP3849523A4 (fr) | Compositions pharmaceutiques ophtalmiques à libération prolongée et utilisations associées |